Sculptor Capital’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Sculptor Capital’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-250,000	Closed	-$2.51M	–	771
2022 Q4	$2.51M	Hold	250,000	–	–	0.04%	333
2022 Q3	$2.46M	Hold	250,000	–	–	0.03%	492
2022 Q2	$2.43M	Hold	250,000	–	–	0.03%	525
2022 Q1	$2.44M	Hold	250,000	–	–	0.02%	576
2021 Q4	$2.42M	Buy	250,000 +125,000	+100%	+$1.23M	0.02%	562
2021 Q3	$1.23M	Buy	+125,000	New	+$1.22M	0.01%	564

Other funds holding ORIA

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Sculptor Capital's ORIA Position: Q1 2023 in Review

Sculptor Capital sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q1 2023, closing a stake of 250,000 shares — an estimated $2.51M sold.

Sculptor Capital first reported a position in ORIA in Q3 2021 and held it in 6 quarters. The position peaked at $2.51M in Q4 2022. 49 funds tracked by Wall St. Rank hold ORIA as of Q1 2023.

Sculptor Capital reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Sculptor Capital sold 250,000 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q1 2023, an estimated $2.51M.
Sculptor Capital first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q3 2021 and held it in 6 quarters.
Sculptor Capital's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $2.51M in Q4 2022.
49 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q1 2023.

Based on Sculptor Capital's 13F filing for Q1 2023, filed 16 May 2023.